Ā | Vitamin C group (nā=ā21) | Placebo group (nā=ā22) | Ā | |
---|---|---|---|---|
Mean (SD) years of age | 32.7 (8.4) | 34.2 (10.3) | tā=ā1.5, dfā=ā41, Pā=ā.5 | |
Number (%) of females | 15 (71.4) | 17 (77.2%) | X2ā=ā.19, dfā=ā1, Pā=ā.6 | |
Marital status n (%) | Single | 7 (31.9%) | 7 (31.8%) | X2ā=ā.1, dfā=ā2, Pā=ā.9 |
Married | 13 (59.1%) | 14 (63.6%) | ||
Divorced | 1 (4.5%) | 1 (4.5%) | ||
Psychotic features | 0 | 0 | - | |
Number (%) of smokers | 2 (9.1%) | 2 (9.1%) | - | |
Positive history of being administered ECT | 0 | 0 | - | |
Mean (SD) of Body Mass Index | 25.1 (3.4) | 26.3 (6.5) | tā=ā.7, dfā=ā42, Pā=ā.4 | |
Citalopram mean (SD) dosage (mg/day) | During first 2Ā weeks | 20.2 (0.) | 20.9 (4.2) | tā=āā1.0, dfā=ā42, Pā=ā.3 |
During weeks 3 and 4 | 24.0 (6.6) | 24.5 (7.3) | tā=āā.2, dfā=ā42, Pā=ā.8 | |
During second month | 35.0 (7.4) | 33.5 (7.4) | tā=āā.6, dfā=ā40, Pā=ā.5 | |
Hamilton Depression Rating Scale score | Baseline | 21.4 (4.1) | 22.4 (3.0) | tā=āā.9, dfā=ā42, Pā=ā.3 |
Week 2 | 15.0 (5.6) | 16.9 (6.0) | tā=ā1.0, dfā=ā42, Pā=ā.4 | |
Week 4 | 11.2 (6.8) | 11.9 (5.9) | tā=āā.3, dfā=ā41, Pā=ā.7 | |
Week 8 | 8.6 (5.2) | 9.3 (6.3) | tā=āā.3, dfā=ā41, Pā=ā.6 | |
Decline of Hamilton Depression Rating Scale score (%) | 60.0 (20.3 | 59.2 (26.9) | tā=āā.1, dfā=ā41, Pā=ā.9 | |
Mean (SD) of Beck Depression Inventory score | Baseline | 23.9 (8.3) | 22.8 (9.8) | tā=āā.3, dfā=ā41, Pā=ā.6 |
Week 2 | 18.0 (11.1) | 17.9 (9.8) | tā=ā.02, dfā=ā41, Pā=ā.9 | |
Week 4 | 14.8 (10.8) | 15.1 (10.4) | tā=ā.1, dfā=ā41, Pā=ā.9 | |
Week 8 | 8.6 (10.7) | 9.0 (9.6) | tā=āā.1, dfā=ā41, Pā=ā.9 | |
Mean (SD) decline of suicidal score | 1.0 (0.9) | 0.9 (0.9) | tā=āā.3, dfā=ā37, Pā=ā.7 |